SCARLATA, GIUSEPPE GUIDO MARIA
 Distribuzione geografica
Continente #
EU - Europa 179
AS - Asia 159
NA - Nord America 130
SA - Sud America 24
AF - Africa 3
Totale 495
Nazione #
US - Stati Uniti d'America 125
SG - Singapore 114
IT - Italia 74
DE - Germania 42
BR - Brasile 19
FI - Finlandia 14
RU - Federazione Russa 13
GB - Regno Unito 11
NL - Olanda 10
CN - Cina 9
HK - Hong Kong 9
IN - India 8
AT - Austria 5
FR - Francia 4
BD - Bangladesh 3
CA - Canada 3
PK - Pakistan 3
BG - Bulgaria 2
EC - Ecuador 2
JP - Giappone 2
MX - Messico 2
PH - Filippine 2
SE - Svezia 2
TR - Turchia 2
UZ - Uzbekistan 2
VN - Vietnam 2
AR - Argentina 1
CL - Cile 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
IL - Israele 1
KW - Kuwait 1
RS - Serbia 1
TW - Taiwan 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 495
Città #
Singapore 87
Santa Clara 38
Munich 30
Turku 11
Ashburn 9
Hong Kong 9
Milan 8
London 7
Chicago 6
Kiel 6
San Nicola Manfredi 6
Hangzhou 5
Rome 5
St Louis 5
Assago 4
Palermo 4
Potenza 4
São Paulo 4
Boardman 3
Brooklyn 3
Catania 3
Chennai 3
Elk Grove Village 3
Helsinki 3
Shanghai 3
St Petersburg 3
Taranto 3
Vienna 3
Bari 2
Belo Horizonte 2
Boston 2
Dhaka 2
Fermo 2
Gatchina 2
Hacienda Ibarra 2
Honolulu 2
Montreal 2
Moscow 2
Naples 2
Nuremberg 2
Padova 2
Stockholm 2
Tashkent 2
The Dalles 2
Thiruvananthapuram 2
Tokyo 2
Yekaterinburg 2
Addis Ababa 1
Ahoskie 1
Akron 1
Amsterdam 1
Ankara 1
As Sālimīyah 1
Atlanta 1
Aversa 1
Bilthoven 1
Bolzano 1
Boydton 1
Bradford 1
Brasília 1
Cairo 1
Campinas 1
Cosenza 1
Cosmorama 1
Curitiba 1
Dallas 1
Fayetteville 1
Florianópolis 1
Guarulhos 1
Hanoi 1
Ho Chi Minh City 1
Jackson 1
Johannesburg 1
Los Angeles 1
Louisville 1
Maltepe 1
Manila 1
Montanha 1
Montevideo 1
Mumbai 1
New York 1
Nilópolis 1
Oklahoma City 1
Perm 1
Philadelphia 1
Plano 1
Poplar 1
Rajkot 1
Ribeirão Preto 1
Rio de Janeiro 1
Rostov-on-Don 1
San Francisco 1
San Luis Potosí City 1
San Miguel de Tucumán 1
Santiago 1
Seattle 1
Secaucus 1
Staten Island 1
São José 1
São José dos Campos 1
Totale 369
Nome #
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 37
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 37
Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey 33
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 32
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 27
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 20
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 19
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 18
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease 18
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 17
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 17
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 16
Is the Mediterranean diet a good preventive measure for NASH? 16
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 14
Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma 14
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition 14
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series 14
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 14
Comment on Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444 13
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 13
The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review 13
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? 12
Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study 11
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection 11
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 11
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 10
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 10
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience 10
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance 9
The levels of inflammatory, angiogenic, and stress biomarkers in plasma of donors depending on anti-SARS-CoV-2 IgG titers 8
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors 8
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease 7
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 7
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 7
Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review 5
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review 5
Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease 4
Should Routine Diagnostics Implement Gut Microbiota Analysis? 2
Totale 553
Categoria #
all - tutte 6.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 8 0 0 1 0 2
2023/202476 12 3 7 7 3 5 6 10 5 0 4 14
2024/2025415 28 7 23 14 43 64 16 20 17 7 67 109
2025/202651 51 0 0 0 0 0 0 0 0 0 0 0
Totale 553